Logo image of CMPO

COMPOSECURE INC-A (CMPO) Stock Fundamental Analysis

NASDAQ:CMPO - Nasdaq - US20459V1052 - Common Stock - Currency: USD

14.21  -0.35 (-2.4%)

After market: 14.21 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CMPO. CMPO was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. CMPO has only an average score on both its financial health and profitability. CMPO has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CMPO was profitable.
CMPO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CMPO reported negative net income in multiple years.
Of the past 5 years CMPO 4 years had a positive operating cash flow.
CMPO Yearly Net Income VS EBIT VS OCF VS FCFCMPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

CMPO has a Return On Assets of -11.02%. This is in the lower half of the industry: CMPO underperforms 62.50% of its industry peers.
CMPO's Return On Invested Capital of 36.62% is amongst the best of the industry. CMPO outperforms 96.88% of its industry peers.
CMPO had an Average Return On Invested Capital over the past 3 years of 52.37%. This is significantly above the industry average of 16.14%.
The 3 year average ROIC (52.37%) for CMPO is well above the current ROIC(36.62%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -11.02%
ROE N/A
ROIC 36.62%
ROA(3y)3.24%
ROA(5y)3.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
CMPO Yearly ROA, ROE, ROICCMPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

CMPO has a Operating Margin of 23.66%. This is amongst the best in the industry. CMPO outperforms 93.75% of its industry peers.
In the last couple of years the Operating Margin of CMPO has declined.
CMPO has a Gross Margin of 51.62%. This is amongst the best in the industry. CMPO outperforms 93.75% of its industry peers.
In the last couple of years the Gross Margin of CMPO has remained more or less at the same level.
Industry RankSector Rank
OM 23.66%
PM (TTM) N/A
GM 51.62%
OM growth 3Y-5.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5YN/A
CMPO Yearly Profit, Operating, Gross MarginsCMPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CMPO is creating value.
Compared to 1 year ago, CMPO has more shares outstanding
CMPO has a better debt/assets ratio than last year.
CMPO Yearly Shares OutstandingCMPO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CMPO Yearly Total Debt VS Total AssetsCMPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

CMPO has an Altman-Z score of 3.73. This indicates that CMPO is financially healthy and has little risk of bankruptcy at the moment.
CMPO has a Altman-Z score of 3.73. This is amongst the best in the industry. CMPO outperforms 81.25% of its industry peers.
There is no outstanding debt for CMPO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0
Altman-Z 3.73
ROIC/WACC4.28
WACC8.55%
CMPO Yearly LT Debt VS Equity VS FCFCMPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M -400M -600M -800M -1B

2.3 Liquidity

CMPO has a Current Ratio of 0.23. This is a bad value and indicates that CMPO is not financially healthy enough and could expect problems in meeting its short term obligations.
CMPO's Current ratio of 0.23 is on the low side compared to the rest of the industry. CMPO is outperformed by 96.88% of its industry peers.
A Quick Ratio of 0.23 indicates that CMPO may have some problems paying its short term obligations.
With a Quick ratio value of 0.23, CMPO is not doing good in the industry: 96.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
CMPO Yearly Current Assets VS Current LiabilitesCMPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

CMPO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.00%.
The Revenue has grown by 20.31% in the past year. This is a very strong growth!
CMPO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.22% yearly.
EPS 1Y (TTM)-1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)20.31%
Revenue growth 3Y16.22%
Revenue growth 5YN/A
Sales Q2Q%-0.12%

3.2 Future

Based on estimates for the next years, CMPO will show a decrease in Earnings Per Share. The EPS will decrease by -1.06% on average per year.
Based on estimates for the next years, CMPO will show a small growth in Revenue. The Revenue will grow by 7.62% on average per year.
EPS Next Y-2.51%
EPS Next 2Y0.24%
EPS Next 3Y-1.06%
EPS Next 5YN/A
Revenue Next Year5.14%
Revenue Next 2Y6.73%
Revenue Next 3Y7.62%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CMPO Yearly Revenue VS EstimatesCMPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CMPO Yearly EPS VS EstimatesCMPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.35, which indicates a correct valuation of CMPO.
75.00% of the companies in the same industry are more expensive than CMPO, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.30, CMPO is valued a bit cheaper.
The Price/Forward Earnings ratio is 14.29, which indicates a correct valuation of CMPO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMPO is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.76. CMPO is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.35
Fwd PE 14.29
CMPO Price Earnings VS Forward Price EarningsCMPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CMPO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CMPO is cheaper than 62.50% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CMPO is valued a bit cheaper than the industry average as 78.13% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.87
EV/EBITDA 12.11
CMPO Per share dataCMPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.24%
EPS Next 3Y-1.06%

0

5. Dividend

5.1 Amount

No dividends for CMPO!.
Industry RankSector Rank
Dividend Yield N/A

COMPOSECURE INC-A

NASDAQ:CMPO (7/11/2025, 8:01:05 PM)

After market: 14.21 0 (0%)

14.21

-0.35 (-2.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)07-31 2025-07-31/amc
Inst Owners59.93%
Inst Owner Change0%
Ins Owners7.85%
Ins Owner Change1.05%
Market Cap1.45B
Analysts81.54
Price Target15.52 (9.22%)
Short Float %23.64%
Short Ratio12.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP-27.68%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.68%
Min EPS beat(2)-7.26%
Max EPS beat(2)28.61%
EPS beat(4)2
Avg EPS beat(4)5.28%
Min EPS beat(4)-7.35%
Max EPS beat(4)28.61%
EPS beat(8)3
Avg EPS beat(8)2.96%
EPS beat(12)4
Avg EPS beat(12)15.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.28%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)-1.29%
Revenue beat(4)1
Avg Revenue beat(4)-0.47%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)3.08%
Revenue beat(8)3
Avg Revenue beat(8)-1.07%
Revenue beat(12)5
Avg Revenue beat(12)0.21%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.85%
EPS NY rev (1m)1.98%
EPS NY rev (3m)6.39%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.27%
Valuation
Industry RankSector Rank
PE 14.35
Fwd PE 14.29
P/S 3.03
P/FCF 15.87
P/OCF 14.71
P/B N/A
P/tB N/A
EV/EBITDA 12.11
EPS(TTM)0.99
EY6.97%
EPS(NY)0.99
Fwd EY7%
FCF(TTM)0.9
FCFY6.3%
OCF(TTM)0.97
OCFY6.8%
SpS4.7
BVpS-0.85
TBVpS-0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.02%
ROE N/A
ROCE 46.35%
ROIC 36.62%
ROICexc 38.09%
ROICexgc 38.09%
OM 23.66%
PM (TTM) N/A
GM 51.62%
FCFM 19.07%
ROA(3y)3.24%
ROA(5y)3.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)52.37%
ROIC(5y)N/A
ROICexc(3y)64.23%
ROICexc(5y)N/A
ROICexgc(3y)64.23%
ROICexgc(5y)N/A
ROCE(3y)66.3%
ROCE(5y)N/A
ROICexcg growth 3Y-41.29%
ROICexcg growth 5YN/A
ROICexc growth 3Y-41.29%
ROICexc growth 5YN/A
OM growth 3Y-5.56%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.2%
GM growth 5YN/A
F-Score3
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 84.18%
Cap/Sales 1.5%
Interest Coverage 6.11
Cash Conversion 80.83%
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z 3.73
F-Score3
WACC8.55%
ROIC/WACC4.28
Cap/Depr(3y)109.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-2.51%
EPS Next 2Y0.24%
EPS Next 3Y-1.06%
EPS Next 5YN/A
Revenue 1Y (TTM)20.31%
Revenue growth 3Y16.22%
Revenue growth 5YN/A
Sales Q2Q%-0.12%
Revenue Next Year5.14%
Revenue Next 2Y6.73%
Revenue Next 3Y7.62%
Revenue Next 5YN/A
EBIT growth 1Y-5.88%
EBIT growth 3Y9.76%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y13.8%
EBIT Next 5YN/A
FCF growth 1Y-3.04%
FCF growth 3Y18.37%
FCF growth 5YN/A
OCF growth 1Y-6.58%
OCF growth 3Y18.54%
OCF growth 5YN/A